Event

• Different HTA Perspectives on Reliably Estimating Treatment Effects

  15 November, 2022, 11 AM-12 PM

• November 17-18: Network Meta-Analysis in Relative Effectiveness Research- Virtual

  Everyday, 17 November, 2022 at 11 AM-18 November, 2022 at 1 PM

• December 1: Use of Propensity Scores in Observational Studies of Treatment Effects- Virtual

  1 December, 2022, 10 AM-2 PM

• Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

  5 December, 2022, 11 AM-12 PM

• December 7-8: Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology- Virtual

  Everyday, 7 December, 2022 at 10 AM-8 December, 2022 at 12 PM

• Strategies and Skills to Land Your First Job: The Interview

  9 December, 2022, 11 AM-12 PM

• December 12-13: Introduction to Patient-Reported Outcomes Assessment: Instrument Development & Evaluation- Virtual

  Everyday, 12 December, 2022 at 10 AM-13 December, 2022 at 12 PM

• Achieving Fit for Purpose Data from Wearables for Age-Related Diseases

  11 January, 2023, 10 AM-11 AM

• January 25-26: Market Access & Value Assessment of Medical Devices- Virtual

  Everyday, 25 January, 2023 at 10 AM-26 January, 2023 at 12 PM

• FDA Patient-Focused Drug Development (PFDD) Guidance - Part 1

  2 February, 2023, 10 AM-11 AM

• Digital Endpoint Adoption: the How, What and Why

  9 February, 2023, 11 AM-12 PM

• February 13-16: Introduction to Health Economics and Outcomes Research- Virtual

  Everyday, 13 February, 2023 at 10 AM-16 February, 2023 at 12 PM

• Preventing, Detecting, and Analyzing Data From Suspected Fraudulent Respondents in Online Surveys, With Examples From Health Preference Studies

  14 February, 2023, 10 AM-11 AM

• Improving Treatment Access and Outcomes by Integrating Social Determinants of Health Data With Real-World Evidence

  21 February, 2023, 11 AM-12 PM

• HEOR Theater - HTA Implementation in the MEA Region – an Overview From WHO and Country Updates

  23 February, 2023, 10 AM-11 AM

• March 1-2: Introduction to Modeling- Virtual

  Everyday, 1 March, 2023 at 10 AM-2 March, 2023 at 12 PM

• FDA Patient-Focused Drug Development (PFDD) Guidance - Part 2

  7 March, 2023, 9 AM-10 AM

• March 8-9: Advanced Patient-Reported Outcomes- Virtual

  Everyday, 8 March, 2023 at 10 AM-9 March, 2023 at 12 PM

• March 15-16: Bayesian Analysis–An Introduction- Virtual

  Everyday, 15 March, 2023 at 10 AM-16 March, 2023 at 12 PM

• HEOR Theater: Student and New Professional Day

  23 March, 2023, 11 AM-12 PM

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10 (current)
• »